Cargando…

Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection

The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis (PrEP) guidelines in June 2012 for men who have sex with men (MSM) who are at risk of HIV infection. With the flurry of data that has been generated in PrEP clinical research since the first guidelin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekker, Linda-Gail, Rebe, Kevin, Venter, Francois, Maartens, Gary, Moorhouse, Michelle, Conradie, Francesca, Wallis, Carole, Black, Vivian, Harley, Beth, Eakles, Robyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843155/ https://www.ncbi.nlm.nih.gov/pubmed/29568613 http://dx.doi.org/10.4102/sajhivmed.v17i1.455

Ejemplares similares

Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update
por: Moorhouse, Michelle, et al.
Publicado: (2015)

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
por: Bekker, Linda-Gail, et al.
Publicado: (2020)

Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
por: Bekker, Linda-Gail, et al.
Publicado: (2021)

Pre-exposure prophylaxis in Southern Africa: feasible or not?
por: Venter, Willem Daniel François, et al.
Publicado: (2015)

Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations
por: Horak, Jaco, et al.
Publicado: (2023)

Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy
por: Meintjes, Graeme, et al.
Publicado: (2015)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

What is the role of CD4 count in a large public health antiretroviral programme?
por: Moorhouse, Michelle, et al.
Publicado: (2016)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
por: Nel, Jeremy, et al.
Publicado: (2020)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy
por: de Cherif, Teresa K Smith, et al.
Publicado: (2009)

Southern African HIV Clinicians Society guidelines for solid organ transplantation in human immunodeficiency virus: An evidence-based framework for human immunodeficiency virus-positive donors and recipients
por: Nel, Jeremy S., et al.
Publicado: (2020)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa
por: Steegen, Kim, et al.
Publicado: (2021)

Southern African HIV Clinicians Society guidelines for harm reduction
por: Scheibe, Andrew, et al.
Publicado: (2020)

Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
por: Meintjes, Graeme, et al.
Publicado: (2015)

Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game?
por: Eakle, Robyn, et al.
Publicado: (2018)

HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project
por: Eakle, Robyn, et al.
Publicado: (2017)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

The role of rilpivirine in Southern Africa
por: Moorhouse, Michelle A., et al.
Publicado: (2019)

Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
por: Leisegang, Rory, et al.
Publicado: (2009)

Evaluating the appropriateness of laboratory testing and antimicrobial use in South African children hospitalized for community-acquired infections
por: Mapala, Lydia, et al.
Publicado: (2022)

Hope for HIV control in southern Africa: The continued quest for a vaccine
por: Bekker, Linda-Gail, et al.
Publicado: (2017)

Cross-sectional study of the health of southern African truck drivers
por: Lalla-Edward, Samanta Tresha, et al.
Publicado: (2019)

Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study
por: Joseph Davey, Dvora, et al.
Publicado: (2022)

Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment
por: Minnis, Alexandra M, et al.
Publicado: (2020)

Pre-exposure Prophylaxis: The Delivery Challenge
por: Venter, Willem D. F.
Publicado: (2018)

Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018
por: Davies, Natasha E.C.G., et al.
Publicado: (2018)

Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence
por: Giovenco, Danielle, et al.
Publicado: (2021)

South African HIV self-testing policy and guidance considerations
por: Venter, Francois, et al.
Publicado: (2017)

Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice
por: Peters, Remco P.H., et al.
Publicado: (2022)

Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa
por: Davey, Dvora L Joseph, et al.
Publicado: (2021)

Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women
por: Bekker, Linda-Gail, et al.
Publicado: (2022)

Erratum: Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice
por: Peters, Remco P.H., et al.
Publicado: (2022)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
por: Mahomed, Kairoonisha, et al.
Publicado: (2020)

Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis
por: Sunseri, Maria, et al.
Publicado: (2018)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Be legally wise: When is parental consent required for adolescents’ access to pre-exposure prophylaxis (PrEP)?
por: Strode, Ann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_68nlh6pr3m0d05a22eikt7j24a